Martin Capital Advisors LLP Sells 96 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Martin Capital Advisors LLP lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 0.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 13,374 shares of the financial services provider’s stock after selling 96 shares during the period. iShares Biotechnology ETF makes up about 1.5% of Martin Capital Advisors LLP’s holdings, making the stock its 21st biggest holding. Martin Capital Advisors LLP’s holdings in iShares Biotechnology ETF were worth $1,817,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in IBB. Glass Jacobson Investment Advisors llc lifted its stake in iShares Biotechnology ETF by 150.6% in the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after buying an additional 122 shares during the period. PCA Investment Advisory Services Inc. bought a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at about $28,000. Values First Advisors Inc. acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at approximately $43,000. Horizon Bancorp Inc. IN bought a new position in iShares Biotechnology ETF during the 3rd quarter worth approximately $44,000. Finally, Tennessee Valley Asset Management Partners acquired a new position in iShares Biotechnology ETF during the fourth quarter valued at approximately $44,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 0.1 %

Shares of NASDAQ IBB traded up $0.08 during midday trading on Friday, reaching $124.72. 1,996,592 shares of the stock were exchanged, compared to its average volume of 1,809,704. The business has a 50-day simple moving average of $135.29 and a two-hundred day simple moving average of $129.51. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $141.16.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were given a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.40%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.